Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies

[1]Aubin H.J., Reimer J., Nutt D.J., Bladström A., Torup L., François C., Chick J.: Clinical relevance of as needed treatment with na-lmefene in alcohol-dependent patients. Eur. Addict. Res., 2015; 21: 160–168 Aubin H.J. Reimer J. Nutt D.J. Bladström A. Torup L. François C. Chick J. Clinical relevance of as needed treatment with na-lmefene in alcohol-dependent patients Eur. Addict. Res 2015 21 160 16810.1159/00037154725832297Search in Google Scholar

[2]Xuan Z., Naimi T.S., Kaplan M.S., Bagge C.L., Few L.R., Maisto S., Saitz R., Freeman R.: Alcohol policies and suicide: A review of the literature. Alcohol Clin. Exp. Res., 2016; 40: 2,043–2,055 Xuan Z. Naimi T.S. Kaplan M.S. Bagge C.L. Few L.R. Maisto S. Saitz R. Freeman R. Alcohol policies and suicide: A review of the literature Alcohol Clin. Exp. Res 2016 40 2 043–2,05510.1111/acer.13203504854727618526Search in Google Scholar

[3]Alasmari F., Goodwani S., McCullumsmith R.E., Sari Y.: Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. Prog. Neurobiol., 2018; 171: 32–49 Alasmari F. Goodwani S. McCullumsmith R.E. Sari Y. Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence Prog. Neurobiol 2018 171 32 4910.1016/j.pneurobio.2018.10.001626146330316901Search in Google Scholar

[4]Anderson R.I., Becker H.C., Adams B.L., Jesudason C.D., Rorick-Kehn L.M.: Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models. Front. Neurosci., 2014; 8: 33 Anderson R.I. Becker H.C. Adams B.L. Jesudason C.D. Rorick-Kehn L.M. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models Front. Neurosci 2014 8 3310.3389/fnins.2014.00033393394524616657Search in Google Scholar

[5]Imperato A., Di Chiara G.: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther., 1986; 239: 219–228 Imperato A. Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol J. Pharmacol. Exp. Ther 1986 239 219 228Search in Google Scholar

[6]Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E.: Excitation of ventral tegmental area dopaminergic and non-dopaminergic neurons by orexins/hypocretins. J. Neurosci., 2003; 23: 7–11 Korotkova T.M. Sergeeva O.A. Eriksson K.S. Haas H.L. Brown R.E. Excitation of ventral tegmental area dopaminergic and non-dopaminergic neurons by orexins/hypocretins J. Neurosci 2003 23 7 1110.1523/JNEUROSCI.23-01-00007.2003Search in Google Scholar

[7]Patyal R., Woo E.Y., Borgland S.L.: Local hypocretin-1 modulates terminal dopamine concentration in the nucleus accumbens shell. Front. Behav. Neurosci., 2012; 6: 82 Patyal R. Woo E.Y. Borgland S.L. Local hypocretin-1 modulates terminal dopamine concentration in the nucleus accumbens shell Front. Behav. Neurosci 2012 6 8210.3389/fnbeh.2012.00082350828523226119Search in Google Scholar

[8]Vena A.A., Gonzales R.A.: Temporal profiles dissociate regional extracellular ethanol versus dopamine concentrations. ACS Chem. Neurosci., 2015; 6: 37–47 Vena A.A. Gonzales R.A. Temporal profiles dissociate regional extracellular ethanol versus dopamine concentrations ACS Chem. Neurosci 2015 6 37 4710.1021/cn500278b430448125537116Search in Google Scholar

[9]Schier C.J., Dilly G.A., Gonzales R.A.: Intravenous ethanol increases extracellular dopamine in the medial prefrontal cortex of the Long-Evans rat. Alcohol Clin. Exp. Res., 2013; 37: 740–747 Schier C.J. Dilly G.A. Gonzales R.A. Intravenous ethanol increases extracellular dopamine in the medial prefrontal cortex of the Long-Evans rat Alcohol Clin. Exp. Res 2013 37 740 74710.1111/acer.12042367628523421849Search in Google Scholar

[10]Adinoff B.: Neurobiologic processes in drug reward and addiction. Harv. Rev. Psychiatry., 2004; 12: 305–320 Adinoff B. Neurobiologic processes in drug reward and addiction Harv. Rev. Psychiatry 2004 12 305 32010.1080/10673220490910844192054315764467Search in Google Scholar

[11]Samson H.H., Pfeffer A.O., Tolliver G.A.: Oral ethanol self-administration in rats: Models of alcohol-seeking behavior. Alcohol. Clin. Exp. Res., 1988; 12: 591–598 Samson H.H. Pfeffer A.O. Tolliver G.A. Oral ethanol self-administration in rats: Models of alcohol-seeking behavior Alcohol. Clin. Exp. Res 1988 12 591 59810.1111/j.1530-0277.1988.tb00248.x3067600Search in Google Scholar

[12]Samson H.H., Tolliver G.A., Pfeffer A.O., Sadeghi K, Haraguchi M.: Relation of ethanol self-administration to feeding and drinking in a nonrestricted access situation in rats initiated to self-administer ethanol using the sucrose-fading technique, Alcohol, 1988; 5: 375–385 Samson H.H. Tolliver G.A. Pfeffer A.O. Sadeghi K Haraguchi M. Relation of ethanol self-administration to feeding and drinking in a nonrestricted access situation in rats initiated to self-administer ethanol using the sucrose-fading technique Alcohol 1988 5 375 38510.1016/0741-8329(88)90024-9Search in Google Scholar

[13]Volkow N.D., Michaelides M., Baler R.: The neuroscience of drug reward and addiction. Physiol. Rev., 2019; 99: 2,115–2,140 Volkow N.D. Michaelides M. Baler R. The neuroscience of drug reward and addiction Physiol. Rev 2019 99 2 115–2,14010.1152/physrev.00014.2018Search in Google Scholar

[14]Mitchell J.M., O’Neil J.P., Janabi M., Marks S.M., Jagust W.J., Fields H.L.: Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci. Transl. Med., 2012; 4: 116ra6 Mitchell J.M. O’Neil J.P. Janabi M. Marks S.M. Jagust W.J. Fields H.L. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens Sci. Transl. Med 2012 4 116ra610.1126/scitranslmed.3002902Search in Google Scholar

[15]Addolorato G., Leggio L., Abenavoli L., Gasbarrini G., Alcoholism Treatment Study Group: Neurobiochemical and clinical aspects of craving in alcohol addiction: A review. Addict. Behav., 2005; 30: 1,209–1,224 Addolorato G. Leggio L. Abenavoli L. Gasbarrini G. Alcoholism Treatment Study Group: Neurobiochemical and clinical aspects of craving in alcohol addiction: A review Addict. Behav 2005 30 1 209–1,22410.1016/j.addbeh.2004.12.011Search in Google Scholar

[16]Koob G.F., Volkow N.D.: Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry, 2016; 3: 760–773 Koob G.F. Volkow N.D. Neurobiology of addiction: A neurocircuitry analysis Lancet Psychiatry 2016 3 760 77310.1016/S2215-0366(16)00104-8Search in Google Scholar

[17]Weiss F., Porrino L.J.: Behavioral neurobiology of alcohol addiction: Recent advances and challenges. J. Neurosci. 2002; 22: 3,332–3,337 Weiss F. Porrino L.J. Behavioral neurobiology of alcohol addiction: Recent advances and challenges J. Neurosci 2002 22 3 332–3,33710.1523/JNEUROSCI.22-09-03332.2002Search in Google Scholar

[18]Barson J.R., Leibowitz S.F.: Orexin/hypocretin system: Role in food and drug overconsumption. Int. Rev. Neurobiol., 2017; 136: 199–237 Barson J.R. Leibowitz S.F. Orexin/hypocretin system: Role in food and drug overconsumption Int. Rev. Neurobiol 2017 136 199 23710.1016/bs.irn.2017.06.006Search in Google Scholar

[19]Holmqvist T., Akerman K.E., Kukkonen J.P.: High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neurosci Lett., 2001; 305: 177–180 Holmqvist T. Akerman K.E. Kukkonen J.P. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides Neurosci Lett 2001 305 177 18010.1016/S0304-3940(01)01839-0Search in Google Scholar

[20]James M.H., Mahler S.V., Moorman D.E., Aston-Jones G.: A decade of orexin/hypocretin and addiction: Where are we now? Curr. Top. Behav. Neurosci., 2017; 33: 247–281 James M.H. Mahler S.V. Moorman D.E. Aston-Jones G. A decade of orexin/hypocretin and addiction: Where are we now? Curr Top. Behav. Neurosci 2017 33 247 28110.1007/7854_2016_57579980928012090Search in Google Scholar

[21]Leonard C.S., Kukkonen J.P.: Orexin/hypocretin receptor signalling: A functional perspective. Br. J. Pharmacol., 2014; 171: 294–313 Leonard C.S. Kukkonen J.P. Orexin/hypocretin receptor signalling: A functional perspective Br. J. Pharmacol 2014 171 294 31310.1111/bph.12296390425323848055Search in Google Scholar

[22]de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S. 2nd, et al.: The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 1998; 95: 322–327 de Lecea L. Kilduff T.S. Peyron C. Gao X. Foye P.E. Danielson P.E. Fukuhara C. Battenberg E.L. Gautvik V.T. Bartlett F.S. 2nd, et al The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity Proc. Natl. Acad. Sci. USA 1998 95 322 32710.1073/pnas.95.1.322182139419374Search in Google Scholar

[23]Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., et al.: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998; 92: 573–585 Sakurai T. Amemiya A. Ishii M. Matsuzaki I. Chemelli R.M. Tanaka H. Williams S.C. Richardson J.A. Kozlowski G.P. Wilson S. et al Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 1998 92 573 58510.1016/S0092-8674(00)80949-6Search in Google Scholar

[24]Scammell T.E., Winrow C.J.: Orexin receptors: Pharmacology and therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol., 2011; 51: 243–266 Scammell T.E. Winrow C.J. Orexin receptors: Pharmacology and therapeutic opportunities Annu. Rev. Pharmacol. Toxicol 2011 51 243 26610.1146/annurev-pharmtox-010510-100528305825921034217Search in Google Scholar

[25]Sakurai T.: The role of orexin in motivated behaviours. Nature Rev. Neurosci., 2014; 15: 719–731 Sakurai T. The role of orexin in motivated behaviours Nature Rev. Neurosci 2014 15 719 73110.1038/nrn383725301357Search in Google Scholar

[26]Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K.: Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol., 2001; 435: 6–25 Marcus J.N. Aschkenasi C.J. Lee C.E. Chemelli R.M. Saper C.B. Yanagisawa M. Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain J. Comp. Neurol 2001 435 6 2510.1002/cne.119011370008Search in Google Scholar

[27]Magga J., Bart G., Oker-Blom C., Kukkonen J.P., Akerman K.E., Näsman J.: Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1. Biochem. Pharmacol., 2006; 71: 827–836 Magga J. Bart G. Oker-Blom C. Kukkonen J.P. Akerman K.E. Näsman J. Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1 Biochem. Pharmacol 2006 71 827 83610.1016/j.bcp.2005.12.02116430869Search in Google Scholar

[28]van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B.: Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/ orexin. J. Neurosci., 1998; 18: 7,962–7,971 van den Pol A.N. Gao X.B. Obrietan K. Kilduff T.S. Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/ orexin J. Neurosci 1998 18 7 962–7,97110.1523/JNEUROSCI.18-19-07962.1998Search in Google Scholar

[29]Acuna-Goycolea C., van den Pol A.N.: Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J. Neurosci., 2009; 29: 1,503–1,513 Acuna-Goycolea C. van den Pol A.N. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin J. Neurosci 2009 29 1 503–1,51310.1523/JNEUROSCI.5147-08.2009275161019193897Search in Google Scholar

[30]Huang M.C., Chen C.H., Chen L.Y., Chang H.M., Chen C.K., Lin S.K., Xu K.: Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation. Psychopharmacology, 2020; 237: 45–53 Huang M.C. Chen C.H. Chen L.Y. Chang H.M. Chen C.K. Lin S.K. Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation Psychopharmacology 2020 237 45 5310.1007/s00213-019-05342-931377886Search in Google Scholar

[31]Randeva H.S., Karteris E., Grammatopoulos D., Hillhouse E.W.: Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: Implications for adrenal function and energy homeostasis. J. Clin. Endocrinol. Metab., 2001; 86: 4,808– 4,813 Randeva H.S. Karteris E. Grammatopoulos D. Hillhouse E.W. Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: Implications for adrenal function and energy homeostasis J. Clin. Endocrinol. Metab 2001 86 4 808– 4,81310.1210/jcem.86.10.792111600545Search in Google Scholar

[32]Fujiki N., Yoshida Y., Ripley B., Honda K., Mignot E., Nishino S.: Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport., 2001; 12: 993–997 Fujiki N. Yoshida Y. Ripley B. Honda K. Mignot E. Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation Neuroreport 2001 12 993 99710.1097/00001756-200104170-00026Search in Google Scholar

[33]Moriguchi T., Sakurai T., Nambu T., Yanagisawa M., Goto K.: Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett., 1999; 264: 101–104 Moriguchi T. Sakurai T. Nambu T. Yanagisawa M. Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia Neurosci. Lett 1999 264 101 10410.1016/S0304-3940(99)00177-9Search in Google Scholar

[34]Mieda M., Williams S.C., Sinton C.M., Richardson J.A., Sakurai T., Yanagisawa M.: Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J. Neurosci., 2004; 24: 10,493–10,501 Mieda M. Williams S.C. Sinton C.M. Richardson J.A. Sakurai T. Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness J. Neurosci 2004 24 10 493–10,50110.1523/JNEUROSCI.3171-04.2004Search in Google Scholar

[35]Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L.: Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response. J. Neurosci., 2004; 24: 11,439–11,448 Winsky-Sommerer R. Yamanaka A. Diano S. Borok E. Roberts A.J. Sakurai T. Kilduff T.S. Horvath T.L. de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response J. Neurosci 2004 24 11 439–11,44810.1523/JNEUROSCI.3459-04.2004Search in Google Scholar

[36]Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., et al.: Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell, 1999; 98: 437–451 Chemelli R.M. Willie J.T. Sinton C.M. Elmquist J.K. Scammell T. Lee C. Richardson J.A. Williams S.C. Xiong Y. Kisanuki Y. et al Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation Cell 1999 98 437 45110.1016/S0092-8674(00)81973-XSearch in Google Scholar

[37]Thiele T.E., Navarro M.: “Drinking in the dark” (DID) procedures: A model of binge-like ethanol drinking in non-dependent mice. Alcohol, 2014; 48: 235–241 Thiele T.E. Navarro M. “Drinking in the dark” (DID) procedures: A model of binge-like ethanol drinking in non-dependent mice Alcohol 2014 48 235 24110.1016/j.alcohol.2013.08.005Search in Google Scholar

[38]Leeman R.F., Heilig M., Cunningham C.L., Stephens D.N., Duka T., O’Malley S.S.: Ethanol consumption: How should we measure it? Achieving consilience between human and animal phenotypes. Addict. Biol., 2010; 15: 109–124 Leeman R.F. Heilig M. Cunningham C.L. Stephens D.N. Duka T. O’Malley S.S. Ethanol consumption: How should we measure it? Achieving consilience between human and animal phenotypes Addict. Biol 2010 15 109 12410.1111/j.1369-1600.2009.00192.xSearch in Google Scholar

[39]Gauvin D.V., Moore K.R., Holloway F.A.: Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn? Alcohol, 1993; 10: 37–43 Gauvin D.V. Moore K.R. Holloway F.A. Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn? Alcohol 1993 10 37 4310.1016/0741-8329(93)90051-OSearch in Google Scholar

[40]Bell R.L., Rodd Z.A., Lumeng L., Murphy J.M., McBride W.J.: The alcohol_‐preferring P rat and animal models of excessive alcohol drinking. Addict. Biol., 2006; 11: 270–288 Bell R.L. Rodd Z.A. Lumeng L. Murphy J.M. McBride W.J. The alcohol_‐preferring P rat and animal models of excessive alcohol drinking Addict. Biol 2006 11 270 28810.1111/j.1369-1600.2005.00029.x16961759Search in Google Scholar

[41]Moore C.F., Lynch W.J.: Alcohol preferring (P) rats as a model for examining sex differences in alcohol use disorder and its treatment. Pharmacol. Biochem. Behav., 2015; 132: 1–9 Moore C.F. Lynch W.J. Alcohol preferring (P) rats as a model for examining sex differences in alcohol use disorder and its treatment Pharmacol. Biochem. Behav 2015 132 1 910.1016/j.pbb.2015.02.014454574225712173Search in Google Scholar

[42]Barson J.R., Ho H.T., Leibowitz S.F.: Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: Role of orexin receptor 2. Addict. Biol., 2015; 20: 469–481 Barson J.R. Ho H.T. Leibowitz S.F. Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: Role of orexin receptor 2 Addict. Biol 2015 20 469 48110.1111/adb.12139419211624712379Search in Google Scholar

[43]Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., Barlett S.E.: Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology, 2008; 199: 109–117 Richards J.K. Simms J.A. Steensland P. Taha S.A. Borgland S.L. Bonci A. Barlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats Psychopharmacology 2008 199 109 11710.1007/s00213-008-1136-5266856318470506Search in Google Scholar

[44]Mayannavar S., Rashmi K.S., Rao Y.D., Yadav S., Ganaraja B.: Effect of orexin A antagonist (SB-334867) infusion into the nucleus accumbens on consummatory behavior and alcohol preference in Wistar rats. Indian J. Pharmacol., 2016; 48: 53–58 Mayannavar S. Rashmi K.S. Rao Y.D. Yadav S. Ganaraja B. Effect of orexin A antagonist (SB-334867) infusion into the nucleus accumbens on consummatory behavior and alcohol preference in Wistar rats Indian J. Pharmacol 2016 48 53 5810.4103/0253-7613.174528477820826997723Search in Google Scholar

[45]Shoblock J.R., Welty N., Aluisio L., Fraser I., Motley S.T., Morton K., Palmer J., Bonaventure P., Carruthers N.I., Lovenberg T.W., et al.: Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psycho-pharmacology, 2011; 215: 191–203 Shoblock J.R. Welty N. Aluisio L. Fraser I. Motley S.T. Morton K. Palmer J. Bonaventure P. Carruthers N.I. Lovenberg T.W. et al Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement Psycho-pharmacology 2011 215 191 20310.1007/s00213-010-2127-x21181123Search in Google Scholar

[46]Moorman D.E., Aston-Jones G.: Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol., 2009; 43: 379_‐386 Moorman D.E. Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats Alcohol 2009 43 379 38610.1016/j.alcohol.2009.07.002274139819671464Search in Google Scholar

[47]Moorman D.E., James M.H., Kilroy E.A., Aston-Jones G.: Orexin/ hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats. Brain Res., 2017; 1654: 34–42 Moorman D.E. James M.H. Kilroy E.A. Aston-Jones G. Orexin/ hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats Brain Res 2017 1654 34 4210.1016/j.brainres.2016.10.018512394427771284Search in Google Scholar

[48]Alcaraz-Iborra M., Navarrete F., Rodríguez-Ortega E., de la Fuente L., Manzanares J., Cubero I.: Different molecular/behavioral endophenotypes in C57BL/6J mice predict the impact of OX1 receptor blockade on binge-like ethanol intake. Front. Behav. Neurosci., 2017; 11: 186 Alcaraz-Iborra M. Navarrete F. Rodríguez-Ortega E. de la Fuente L. Manzanares J. Cubero I. Different molecular/behavioral endophenotypes in C57BL/6J mice predict the impact of OX1 receptor blockade on binge-like ethanol intake Front. Behav. Neurosci 2017 11 18610.3389/fnbeh.2017.00186564130129066961Search in Google Scholar

[49]Lei K., Wegner S.A., Yu J.H., Hopf F.W.: Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice. Neuropharmacology, 2016; 110: 431–437 Lei K. Wegner S.A. Yu J.H. Hopf F.W. Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice Neuropharmacology 2016 110 431 43710.1016/j.neuropharm.2016.08.008506593827523303Search in Google Scholar

[50]Lei K., Wegner S.A., Yu J.H., Mototake A., Hu B., Hopf F.W.: Nucleus accumbens shell and mPFC but not insula orexin-1 receptors promote excessive alcohol drinking. Front. Neurosci., 2016; 10: 400 Lei K. Wegner S.A. Yu J.H. Mototake A. Hu B. Hopf F.W. Nucleus accumbens shell and mPFC but not insula orexin-1 receptors promote excessive alcohol drinking Front. Neurosci 2016 10 40010.3389/fnins.2016.00400500404327625592Search in Google Scholar

[51]Olney J.J., Navarro M., Thiele T.E.: Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity. Alcohol. Clin. Exp Res., 2015; 39: 21–29 Olney J.J. Navarro M. Thiele T.E. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity Alcohol. Clin. Exp Res 2015 39 21 2910.1111/acer.12591438786825623402Search in Google Scholar

[52]Voorhees C.M., Cunningham C.L.: Involvement of the orexin/ hypocretin system in ethanol conditioned place preference. Psychopharmacology, 2011; 214: 805–818 Voorhees C.M. Cunningham C.L. Involvement of the orexin/ hypocretin system in ethanol conditioned place preference Psychopharmacology 2011 214 805 81810.1007/s00213-010-2082-6306385721107540Search in Google Scholar

[53]Lê A.D., Ko J., Chow S., Quan B.: Alcohol consumption by C57BL/6, BALB/c, and DBA/2 mice in a limited access paradigm. Pharmacol. Biochem. Behav., 1994; 47: 375–378 Lê A.D. Ko J. Chow S. Quan B. Alcohol consumption by C57BL/6, BALB/c, and DBA/2 mice in a limited access paradigm Pharmacol. Biochem. Behav 1994 47 375 37810.1016/0091-3057(94)90026-4Search in Google Scholar

[54]Mendoza-Ruiz L.G., Vázquez-León P., Martínez-Mota L., Juan E.R., Miranda-Páez A.: Forced ethanol ingestion by Wistar rats from a juvenile age increased voluntary alcohol consumption in adulthood, with the involvement of orexin-A. Alcohol, 2018; 70: 73–80 Mendoza-Ruiz L.G. Vázquez-León P. Martínez-Mota L. Juan E.R. Miranda-Páez A. Forced ethanol ingestion by Wistar rats from a juvenile age increased voluntary alcohol consumption in adulthood, with the involvement of orexin-A Alcohol 2018 70 73 8010.1016/j.alcohol.2018.01.00829803804Search in Google Scholar

[55]Olney J.J., Navarro M., Thiele T.E.: The role of orexin signaling in the ventral tegmental area and central amygdala in modulating binge-like ethanol drinking behavior. Alcohol. Clin. Exp. Res., 2017; 41: 551–561 Olney J.J. Navarro M. Thiele T.E. The role of orexin signaling in the ventral tegmental area and central amygdala in modulating binge-like ethanol drinking behavior Alcohol. Clin. Exp. Res 2017 41 551 56110.1111/acer.13336533229928097729Search in Google Scholar

[56]Brown R.M., Khoo S.Y., Lawrence A.J.: Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. Int. J. Neuropsychopharm., 2013; 16: 2,067–2,079 Brown R.M. Khoo S.Y. Lawrence A.J. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats Int. J. Neuropsychopharm 2013 16 2 067–2,07910.1017/S146114571300033323601187Search in Google Scholar

[57]Jupp B., Krivdic B., Krstew E., Lawrence A.J.: The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res., 2011; 1,391: 54–59 Jupp B. Krivdic B. Krstew E. Lawrence A.J. The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats Brain Res 2011 1,391 54 5910.1016/j.brainres.2011.03.04521439948Search in Google Scholar

[58]Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B.: The orexin system regulates alcohol-seeking in rats. Br. J. Pharmacol., 2006; 148: 752–759 Lawrence A.J. Cowen M.S. Yang H.J. Chen F. Oldfield B. The orexin system regulates alcohol-seeking in rats Br. J. Pharmacol 2006 148 752 75910.1038/sj.bjp.0706789161707416751790Search in Google Scholar

[59]Dhaher R., Hauser S.R., Getachew B., Bell R.L., McBride W.J., McKinzie D.L., Rodd Z.A.: The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J. Addict. Med., 2010; 4: 153–159 Dhaher R. Hauser S.R. Getachew B. Bell R.L. McBride W.J. McKinzie D.L. Rodd Z.A. The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats J. Addict. Med 2010 4 153 15910.1097/ADM.0b013e3181bd893f294364220871792Search in Google Scholar

[60]Lopez M.F., Moorman D.E., Aston-Jones G., Becker H.C.: The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain. Res., 2016; 1,636: 74–80 Lopez M.F. Moorman D.E. Aston-Jones G. Becker H.C. The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice Brain. Res 2016 1,636 74 8010.1016/j.brainres.2016.01.049480860526851547Search in Google Scholar

[61]Brown R.M., Kim A.K., Khoo S.Y., Kim J.H., Jupp B., Lawrence A.J.: Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats. Addic. Biol., 2016; 21: 603–612 Brown R.M. Kim A.K. Khoo S.Y. Kim J.H. Jupp B. Lawrence A.J. Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats Addic. Biol 2016 21 603 61210.1111/adb.1225125899624Search in Google Scholar

[62]Srinivasan S., Simms J.A., Nielsen C.K., Lieske S.P., Bito-Onon J.J., Yi H., Hopf F.W., Bonci A., Bartlett S.E.: The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PLoS One, 2012; 7: e44726 Srinivasan S. Simms J.A. Nielsen C.K. Lieske S.P. Bito-Onon J.J. Yi H. Hopf F.W. Bonci A. Bartlett S.E. The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration PLoS One 2012 7 e4472610.1371/journal.pone.0044726344861523028593Search in Google Scholar

[63]Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T.: Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 2006; 26: 398-405 Narita M. Nagumo Y. Hashimoto S. Narita M. Khotib J. Miyatake M. Sakurai T. Yanagisawa M. Nakamachi T. Shioda S. Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine J. Neurosci 2006 26 398 40510.1523/JNEUROSCI.2761-05.2006667441016407535Search in Google Scholar

[64]Wang B., You Z.B., Wise R.A.: Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: Independence from the local corticotropin-releasing factor network. Biol. Psychiatry, 2009; 65: 857–862 Wang B. You Z.B. Wise R.A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: Independence from the local corticotropin-releasing factor network Biol. Psychiatry 2009 65 857 86210.1016/j.biopsych.2009.01.018270587519251246Search in Google Scholar

[65]Łupina M., Tarnowski M., Baranowska-Bosiacka I., Talarek S., Listos P., Kotlińska J., Gutowska I., Listos J.: SB-334867 (an orexin-1 receptor antagonist) effects on morphine-induced sensitization in mice - a view on receptor mechanisms. Mol. Neurobiol., 2018; 55: 8473–8485 Łupina M. Tarnowski M. Baranowska-Bosiacka I. Talarek S. Listos P. Kotlińska J. Gutowska I. Listos J. SB-334867 (an orexin-1 receptor antagonist) effects on morphine-induced sensitization in mice - a view on receptor mechanisms Mol. Neurobiol 2018 55 8473 848510.1007/s12035-018-0993-0615372029557083Search in Google Scholar

[66]Mahler S.V., Smith R.J., Moorman D.E., Sartor G.C., Aston-Jones G.: Multiple roles for orexin/hypocretin in addiction. Prog. Brain Res., 2012; 198: 79–121 Mahler S.V. Smith R.J. Moorman D.E. Sartor G.C. Aston-Jones G. Multiple roles for orexin/hypocretin in addiction Prog. Brain Res 2012 198 79 12110.1016/B978-0-444-59489-1.00007-0364389322813971Search in Google Scholar

[67]Schoedel K.A., Sun H., Sellers E.M., Faulknor J., Levy-Cooperman N., Li X., Kennedy W., Cha J.H., Lewis N.M., Liu W., et al.: Assessment of the abuse potential of the orexin receptor antagonist, suvorexant, compared with zolpidem in a randomized crossover study. J. Clin. Psychopharmacol. 2016; 36: 314–323 Schoedel K.A. Sun H. Sellers E.M. Faulknor J. Levy-Cooperman N. Li X. Kennedy W. Cha J.H. Lewis N.M. Liu W. et al Assessment of the abuse potential of the orexin receptor antagonist, suvorexant, compared with zolpidem in a randomized crossover study J. Clin. Psychopharmacol 2016 36 314 32310.1097/JCP.000000000000051627253658Search in Google Scholar

[68]Sanchez-Alavez M., Benedict J., Wills D.N., Ehlers C.L.: Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal. Sleep, 2019; 42: zsz020 Sanchez-Alavez M. Benedict J. Wills D.N. Ehlers C.L. Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal Sleep 2019 42 zsz02010.1093/sleep/zsz020644829530715515Search in Google Scholar

[69]Terán A., Majadas S., Galan J.: Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study. Subst. Use Misuse., 2008; 43: 2,169–2,171 Terán A. Majadas S. Galan J. Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study Subst. Use Misuse 2008 43 2 169–2,17110.1080/1082608080229024019085442Search in Google Scholar

[70]Brower K.J., Aldrich M.S., Robinson E.A., Zucker R.A., Greden J.F.: Insomnia, self-medication, and relapse to alcoholism. Am. J. Psychiatry, 2001; 158: 399–404 Brower K.J. Aldrich M.S. Robinson E.A. Zucker R.A. Greden J.F. Insomnia, self-medication, and relapse to alcoholism Am. J. Psychiatry 2001 158 399 40410.1176/appi.ajp.158.3.399300854211229980Search in Google Scholar

[71]Wiskerke J., James M.H., Aston-Jones G.: The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Res., 2020; 1,731: 146222 Wiskerke J. James M.H. Aston-Jones G. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task Brain Res 2020 1,731 14622210.1016/j.brainres.2019.04.017708320031002819Search in Google Scholar